Black Rock Inc. Corcept Therapeutics Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
467Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA9.68MShares$853 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$681 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$552 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$341 Million5.83% of portfolio
-
State Street Corp Boston, MA2.97MShares$262 Million0.01% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.44B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...